Helius Medical Technologies - Home

SIGNUP FOR NEWSLETTER

TSX: HSM     NASDAQ: HSDT

Call us: +1 877-564-0008

Menu

Stock Quote - HSM-T

*Delayed quote courtesy of Google.

Stock Quote - HSDT

*Delayed quote courtesy of Google.

2021 News

Filters
List of articles in category 2021 News
Title Date
Helius Medical Technologies, Inc. to Participate in 1x1 Meetings at 12th Annual Craig-Hallum Alpha Select Conference on November 16, 2021 15 Nov, 2021
Helius Medical Technologies, Inc. Announces Closing of $11.1 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option 12 Nov, 2021
Helius Medical Technologies, Inc. Reports Third Quarter 2021 Financial Results 10 Nov, 2021
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering of Common Stock 10 Nov, 2021
Helius Medical Technologies, Inc. Announces Proposed Underwritten Public Offering of Common Stock 09 Nov, 2021
Helius Medical Technologies, Inc. Launches Therapeutic Experience Program; NYU Langone Health Is Initial Clinical Trial Site 08 Nov, 2021
Helius Medical Technologies, Inc. Receives PoNS® Market Authorization in Australia 04 Nov, 2021
Helius Medical Technologies, Inc. to Release Third Quarter 2021 Financial Results on November 10, 2021 01 Nov, 2021
Helius Medical Technologies, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) 29 Oct, 2021
Helius Medical Technologies, Inc. to Present at the Dawson James Small Cap Growth Conference 12 Oct, 2021
Helius Medical Technologies, Inc. to Present at the Benzinga Healthcare Small Cap Conference 22 Sep, 2021
Helius Medical Technologies, Inc. Appoints Paul Buckman to its Board of Directors 14 Sep, 2021
Helius Medical Technologies, Inc. to Present at the H.C. Wainwright 23rd Annual Global Investment Conference 07 Sep, 2021
Helius Medical Technologies, Inc. Announces Voluntary De-Listing from Toronto Stock Exchange 25 Aug, 2021
Helius Medical Technologies, Inc. Announces FDA Breakthrough Device Designation for the Treatment of Dynamic Gait and Balance Deficits Following a Stroke 17 Aug, 2021
Helius Medical Technologies, Inc. Reports Second Quarter 2021 Financial Results 12 Aug, 2021
Helius Medical Technologies, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) 11 Aug, 2021
Helius Medical Technologies, Inc. Launches New Website for U.S.-Based Patients and Physicians 11 Aug, 2021
Helius Medical Technologies, Inc. to Present at Two Upcoming Investor Conferences in July 12 Jul, 2021
Helius Medical Technologies, Inc. Appoints Antonella Favit-Van Pelt, M.D., Ph.D. as Chief Medical Officer 08 Jul, 2021
Helius Medical Technologies, Inc. to Participate in the Annual World Congress of the Society for Brain Mapping and Therapeutics 07 Jul, 2021
Helius Medical Technologies, Inc. to Release Second Quarter of Fiscal Year 2021 Financial Results on August 12, 2021 30 Jun, 2021
Helius Medical Technologies, Inc. Expands Executive Leadership Team with the Appointment of Dane C. Andreeff as President and Chief Executive Officer and Jeffrey S. Mathiesen as Chief Financial Officer 15 Jun, 2021
Helius Medical Technologies, Inc. to Participate in Noble Capital Markets’ Virtual Road Show Series 08 Jun, 2021
Helius Medical Technologies, Inc. Appoints Frederick Fantazzia as Vice President of Sales & Marketing, North America 02 Jun, 2021
Helius Medical Technologies, Inc. Reports First Quarter 2021 Financial Results 17 May, 2021
Helius Medical Technologies, Inc. to Present at the Planet MicroCap Showcase on April 21st 15 Apr, 2021
Helius Medical Technologies, Inc. to Release First Quarter of Fiscal Year 2021 Financial Results on May 17, 2021 07 Apr, 2021
Helius Medical, Inc Receives U.S. Marketing Authorization for the PoNS™ Device 29 Mar, 2021
Helius Medical Technologies, Inc. to Present at the Investor Summit Group’s Q1 Virtual Summit on March 23rd 17 Mar, 2021
Helius Medical Technologies, Inc. Appoints Sherrie Perkins to its Board of Directors 17 Mar, 2021
Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results 10 Mar, 2021
Helius Medical Technologies to Release Fourth Quarter and Fiscal Year 2020 Financial Results on March 10, 2021 02 Feb, 2021
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option 01 Feb, 2021
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market 28 Jan, 2021
Helius Medical Technologies, Inc. Comments on the Centers for Medicare & Medicaid Services’ Announcement Regarding New Medicare Coverage Pathway for Breakthrough Medical Devices 20 Jan, 2021
Helius Medical Technologies, Inc. Regains Compliance with Nasdaq Listing Standards 19 Jan, 2021
Helius Medical Technologies, Inc. to Present at the Noble Capital Markets 17th Annual Small & Microcap Investor Conference 15 Jan, 2021
Helius Medical Technologies, Inc. Submits Response to U.S. FDA in Pursuit of De Novo Classification and Clearance of the PoNS™ Device for the Treatment of Gait Deficit Due to Symptoms of Multiple Sclerosis 11 Jan, 2021
Helius Medical Technologies, Inc. Comments on Unusual Market Activity 05 Jan, 2021
Helius Medical Technologies, Inc. to Present at Four Upcoming Investor Conferences in January 04 Jan, 2021